Arbro Pharmaceuticals Limited

Arbro has achieved new heights in manufacturing and marketing of diverse range of products in oral doses forms such as pharmaceutical capsules, pharmaceutical tablets, dry syrups, generic losartan potassium, liquids, oral powders with a range of more than 500 products. Arbro has been catering to a large segment of customers ensuring quality, timely delivery & total customer satisfaction.

Arbro has a well equipped Research & Development center to ensure highest quality standards  with a pool of experienced scientists and medical professionals to produce the most advanced range of safe, effective and affordable medicines.

Arbro has dedicated regulatory affairs department responsible for the registration of products in various countries. Our team of regulatory affairs experts plays a pivotal role from initiation to completion of project, ensuring compliance with applicable laws & regulations throughout the process. We, at Arbro, meticulously review all applications to ensure they have been completed in accordance with regulatory requirement. We have successfully submitted numerous dossiers for regulated & semi-regulated markets.

Arbro maintains strict quality parameters for the manufacturing and distribution of pharmaceutical capsules and tablets. All processes are backed by sophisticated quality control system ensuring quality products at each and every step from acquiring of raw material to the finished formulation to meet or exceed the customer satisfaction. Documentations and facilities maintenance is in accordance with WHO-Good Manufacturing Practices guidelines.

Our range of products includes generic losartan potassium, pharmaceutical capsules, antibiotic drugs, generic losartan potassium, antibacterial tablets, analgesic drugs, antipyretic tablets, anti-inflammatory medicines, antihypertensive & cardiac, antiamoebic drugs, antifungal drugs, erectile dysfunction, antacid, antiulcerant drugs, brain activators, cns depressants, antitubercular drugs, vitamin tablets, nutritional drugs, veterinary drugs, sex drive enhancers, sex enhancement drugs etc.

International Market:

• Numerous products are registered and are being regularly exported to various countries like Afghanistan, Iraq, Vietnam, Ghana, Nigeria, CIS and other African Countries etc.
  
• Export House Status has been accorded by Ministry of Commerce, Govt. of India.
  
• Ready availability of dossiers for registration of vast number of products.
  

Domestic Market:

Approved regular supplier of medicines to Govt. institutions like Railways, Central Govt. Health Scheme, Major hospitals like RML Hospital, LRS Hospital, Kalawati Saran Hospital, G.B. Pant Hospital, SVBP Hospital Meerut, Safdarjung Hospital, Municipal Corporation of Delhi, Assam Rifles, J&K Hospitals, and Medical Stores Depot for various states like Delhi Haryana, Himachal Pradesh, Punjab, and Uttar Pradesh etc.

Arbro’s commitment to innovation & innovative technologies has lead to collaborations with leading institutions. Arbro has tapped the rich scientific academic talent pool of these institutes to further develop and commercialize technologies developed by them:

• Development of Anthrax Vaccine in collaboration with Jawaharlal Nehru University(JNU) & Department of Science & Technology (DST) under the Drug & Pharmaceutical Research Program(DPRP).
  
• Licensed technology for TB diagnosis from All India Institute Of Medical Science (AIIMS).
  
• Development of novel drug delivery system in collaboration with Jamia Hamdard and Development of Science & Technology (DST) under the Drugs & Pharmaceutical Research Program( DPRP).
  

ARBRO manufactures a widespread range of brand pharmaceutical formulation products in oral dosage form. Apart from the main activities (production of our own commercial range), contract manufacturing of oral dosage forms are also performed. As a private-owned and fully independent pharmaceutical formulation company, ARBRO offers flexible terms of trade and gives each customer a customized attention. At Arbro, we understand the required quality standards and practices for our customer. Each pharmaceutical capsule and tablet passes through multiple channels of product analysis and testing at our quality control department during production. The modern production line ensures latest packing, Compression and granulation techniques required for GMP standards. Our infrastructure backed by our technical team has played a vital role in our success story.

Arbro has also set up an Animal Health Division (AHD), which primarily markets feed supplements & Veterinary medicines for this segment. AHD is strongly positioned in several states in India and expanding markets in Domestic & International Arena.

Some leading products in this line includes:

• Suphadiazine & Trimethoprim Tablets B.P Vet
• Albendazole Tablets U.S.P. (Vet)
• Arotone Bolus
• Arofer Bolus
• Agrivit Vet
• Caltone-D Vet
• Nutrivit-M Vet

ARBRO’s Analytical Laboratory is ISO 9001:2000 certified, accredited by NABL (ISO/IEC 17025:2005) and recognized by Drugs control Department , Directorate of ISM & H, DST, EIC/EIA, BIS, APEDA and Spices Board of India etc. The scope of services includes:

• Pharmacopoeial analysis of drug products, drug substances, cosmetics, chemicals & excipients covering instrumental, chemical, microbiological and physical evaluation
  
• Analytical & Bioanalytical method development and validation
  
• Stability studies
  
• Microbiological testing
  
• Analysis of Food Products, Water, Waste Water
  
• Analysis of Building Construction Materials, Effluents, Environmental Monitoring.

Continuing its glorious services Arbro has set up Auriga Research Limited as a dedicated & promising Contract Research Organization for conducting Bioavailability & Bioequivalence Studies as per ICH Guidelines. At present this Center is audited & approved by DCGI for conducting BA / BE Studies. Our state of the art facility offers:

• Bioavailability and Bioequivalence Studies including Fasting/Food Effect Studies, Interaction studies, Multiple dose and steady state studies etc
  
• Complete Bio- Analytical Services
  
• Clinical Trials Phase II to IV
  
• Pharmacokinetics & Pharmacodynamic Studies
  
• Clinical Trials Formulation development & Manufacturing
  

The BE & BA studies at ARL are carried out as per detailed internal SOP’s and applicable regulatory guidelines. The Bio-Analytical activities are conducted at ARL’s Analytical Division.

The Molecular Biology Division works with prominent institutions & Organizations like Department of Biotechnology (DBT), Department of science & Technology (DST). It has excellent infrastructure available with optimum technical work force. We offer the following services:

• Development & production of custom assay for PCR,RT-PCR, Nucleic Acid, Sequencing, ELISA and other platforms
  
• Sequencing based kits and tests for HCV and HIV genotyping
  
• Quantitative & Qualitative test by RT-PCR for TB,HCV,HBV and HIV
  
• Rapid detection pathogens in food samples
  
• Detection & quantification of genetically modified organisms
  

Arbro is committed towards quality excellence. The manufacturing facility has distinct areas as Administration Area, Change Room Area, Raw Material Storage Area, Packing Material Storage Area, Tablet Section Area, Capsule & Powder Section, Liquid Section Area, Finished Goods Storage Area & Quality Control Laboratory.

Salient Features:

• Established in the year 1985
• Schedule-M Compliant.
• ISO-9001-2000 Certified unit.
• WHO approved for ß-Lactam group of Tablets, Capsules, Dry Syrup and Non ß-Lactam Group of Compressed Tablets.
• Packing includes Aluminum Strips, Blister, Alu/Alu, Sachets, HDP and food grade PET bottles.
• Closed Loop water purification system to reduce the risk of biological contamination in the distribution network and inhibit bacterial growth and their resultant endotoxin.
• Export oriented unit
• More than 6000 sq ft. of area under development for further expansion of manufacturing operation.

Current Production Capacity per Shift:

• Compressed Tablets: 4 Million Units
• Hard Gelatin Capsules: 0.5 Million Units
• Oral Liquids: 25,000 Units
• Dry Syrups: 10,000 Units

Our vision is Product Innovation, Technology Upgradation thereby strengthening our position to strive for leadership in pharmaceutical & allied services. At ARBRO, we believe in 'Excellence Through Quality'.

Our mission is to provide humanity as a whole with a wide choice of cost effective quality products & services for the improvement of health & treatment of medical conditions.